1. Home
  2. CALC vs PYN Comparison

CALC vs PYN Comparison

Compare CALC & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • PYN
  • Stock Information
  • Founded
  • CALC 2011
  • PYN 2002
  • Country
  • CALC United States
  • PYN United States
  • Employees
  • CALC N/A
  • PYN N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • PYN Investment Managers
  • Sector
  • CALC Health Care
  • PYN Finance
  • Exchange
  • CALC Nasdaq
  • PYN Nasdaq
  • Market Cap
  • CALC 36.0M
  • PYN 34.5M
  • IPO Year
  • CALC N/A
  • PYN N/A
  • Fundamental
  • Price
  • CALC $2.61
  • PYN $5.84
  • Analyst Decision
  • CALC Strong Buy
  • PYN
  • Analyst Count
  • CALC 5
  • PYN 0
  • Target Price
  • CALC $18.20
  • PYN N/A
  • AVG Volume (30 Days)
  • CALC 31.0K
  • PYN 19.9K
  • Earning Date
  • CALC 03-27-2025
  • PYN 01-01-0001
  • Dividend Yield
  • CALC N/A
  • PYN 5.07%
  • EPS Growth
  • CALC N/A
  • PYN N/A
  • EPS
  • CALC N/A
  • PYN N/A
  • Revenue
  • CALC N/A
  • PYN N/A
  • Revenue This Year
  • CALC N/A
  • PYN N/A
  • Revenue Next Year
  • CALC N/A
  • PYN N/A
  • P/E Ratio
  • CALC N/A
  • PYN N/A
  • Revenue Growth
  • CALC N/A
  • PYN N/A
  • 52 Week Low
  • CALC $2.05
  • PYN $4.84
  • 52 Week High
  • CALC $6.27
  • PYN $6.60
  • Technical
  • Relative Strength Index (RSI)
  • CALC 43.94
  • PYN 60.65
  • Support Level
  • CALC $2.32
  • PYN $5.68
  • Resistance Level
  • CALC $3.05
  • PYN $5.77
  • Average True Range (ATR)
  • CALC 0.27
  • PYN 0.04
  • MACD
  • CALC -0.01
  • PYN 0.02
  • Stochastic Oscillator
  • CALC 43.29
  • PYN 89.47

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest

PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.

Share on Social Networks: